What is a Glycoprotein?

Glycoproteins are molecules that comprise of protein and carbohydrate chains that are involved in many physiological functions including immunity. Many viruses have glycoproteins that help them enter bodily cells, but can also serve to be important therapeutic or preventative targets.

Image Credit: StudioMolekuul/Shutterstock.com

What are Glycoproteins?

Glycoproteins are proteins containing glycans attached to amino acid side chains. Glycans are oligosaccharide chains; which are saccharide polymers, that can attach to either lipids (glycolipids) or amino acids (glycoproteins). Typically, these bonds are formed through a process called glycosylation.

Glycosylation occurs on a majority of proteins post-translationally with most RER synthesized proteins undergoing glycosylation. There are different forms of glycosylation that attach specific glycans to proteins and lipids.

For example, N-glycosylation (attachment of glycans to nitrogen on the amine side chain of asparagine) and O-glycosylation (attachment of glycans to oxygen on serine and/or threonine). Specific sugars (glycans) that can be attached to proteins or lipids in humans include β-D-Glucose (Glc) and β-D-Galactose (Gal).

Glycoproteins in Health & Disease

Glycoproteins are incredibly diverse and serve many functions in the body. Some provide structure e.g. collagens, others are involved in immunity e.g. immunoglobulins (such as IgG). Mucins are secreted into mucus of the respiratory and digestive tracts where the specific mucins can retain water thus allowing mucus to serve as an effective lubricant.

Specific glycoproteins (and glycolipids) present on the surface of red blood cells determine blood group type. A-oligosaccharide for A group, B-oligosaccharide for B group, both A & B oligosaccharides for AB group, and the absence of both A & B for O group (H-oligosaccharide precursor only).

The presence of Rh factor (an antigen) determines Rh+ groups, whereas the absence of the Rh antigen leads to Rh groups after ABO determination.

Certain hormones are glycoproteins including follicle-stimulating hormone (FSH) – a gonadotropin hormone that has several functions in development, growth, puberty, and reproduction. Others include erythropoietin – a cytokine secreted by the kidneys that stimulate red blood cell production in bone marrow in high levels in response to hypoxia (low levels normally).  

Many viruses have surface glycoproteins called spike domains; S (including SARS-CoV-2; the virus causing COVID-19. -discussed below) which enable viruses to bind to their target receptors and enter cells.

Normally these surface glycoproteins can also serve as natural neutralizing targets for antibodies produced by the body in fighting off an infection and conferring some degree of future immunity.

Some viruses including HIV, however, have heavily glycosylated S-domains with an abundance of glycans that interfere with antibody binding and recognition thus making viruses such as HIV more evasive and difficult to fully treat.

Glycoproteins and COVID-19

β-coronaviruses – including MERS-CoV (MERS), SARS-CoV (SARS), and SARS-CoV-2 (COVID19) – enter the respiratory (and digestive) epithelia through their spike glycoprotein (S). The viruses bind to the ACE2 receptor through their SB (spike domain B) – which appears ‘crown-like’ and gives rise to the name ‘corona’-virus.

Coronaviruses also require TMPRSS2 to prime the SB-glycoprotein to enter cells through endocytosis.

The SB domain of β-coronaviruses is also the main site for antibodies to neutralize the viruses. It is also therefore the target for any successful vaccination for COVID-19 to target the S glycoprotein on the surface of SARS-CoV-2. Furthermore, polyclonal sera (in mice) can inhibit SARS-CoV-2 entry into cells by blocking the SB domain.

It is important to note, that there are no successful vaccinations for any human coronavirus to date, although significant progress is being made in the development of vaccines for COVID-19 by several groups worldwide.

SARS dissipated from the population and MERS was limited to the Middle East, thus the need for vaccines was not a top priority. However, with COVID-19 being a global pandemic (the first since 1918 influenza pandemic), the need to produce a successful vaccine is a top global priority.

As with many coronaviruses (cold-causing) and influenza viruses (flu causing), the surface S-domains are constantly changing (mutating) hence why have seasonal epidemics each year, despite the presence of antibodies for previous strains.

Although SARS-CoV-2 has mutated into many different variants, overall, the viral structure of the S-domain has remained relatively stable, thus a vaccine may be more promising. Of course, only time will tell if SARS-CoV-2 vaccines will be successful or not.

In summary, glycoproteins are molecules of oligosaccharides (glycans) linked to amino acid side chains of proteins that serve a multitude of physiological functions. These functions vary from structural support such as collagens to determining blood group type Glycoproteins are also present on virus surfaces that enable binding to bodily receptors.

SARS-CoV-2 (causes COVID-19) has a spike-domain (a glycoprotein) that binds to ACE2 receptors in the lungs and interfering with the spike domain may be a potential vaccine target as well as other therapeutic targets.

Image Credit: Andrii Vodolazhskyi/Shutterstock.com


  • Gaunitz et al, 2017. Recent Advances in the Analysis of Complex Glycoproteins. Annal Chem. 89(1):389-413 https://pubmed.ncbi.nlm.nih.gov/28105826/
  • Ruddock & Molinari, 2006. N-glycan Processing in ER Quality Control. J Cell Sci. 119(Pt21):4373-80 https://pubmed.ncbi.nlm.nih.gov/17074831/
  • Ou et al, 2020. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 11: 1620. https://pubmed.ncbi.nlm.nih.gov/32221306/
  • Walls et al, 2020. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell 181(2):281-292.e6 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102599/
  • Nature.com, 2020. Coronavirus vaccine trials have delivered their first results — but their promise is still unclear https://www.nature.com/articles/d41586-020-01092-3

Further Reading

  • All Coronavirus Disease COVID-19 Content
  • What Mutations of SARS-CoV-2 are Causing Concern?
  • What is the Clinical Impact of COVID-19 on Cancer Patients?
  • Can Pets Get COVID-19?
  • An Overview of the SARS-CoV-2 Vaccines

Last Updated: Jan 29, 2021

Written by

Osman Shabir

Osman is a Neuroscience PhD Research Student at the University of Sheffield studying the impact of cardiovascular disease and Alzheimer's disease on neurovascular coupling using pre-clinical models and neuroimaging techniques.

Source: Read Full Article